Drug profile · INN
cloxacillin sodium
CLOXACILLIN SODIUM
cloxacillin sodium (CLOXACILLIN SODIUM) is a penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — cloxacillin sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
cloxacillin sodium (CLOXACILLIN SODIUM) is a penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Penicillin-binding protein inhibitor
Primary target: Penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cloxacillin sodium?
cloxacillin sodium (CLOXACILLIN SODIUM) is a penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cloxacillin sodium?
CLOXACILLIN SODIUM is a marketed brand name for cloxacillin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cloxacillin sodium?
cloxacillin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.